Company completes spin-off of seed business, well positioned to advance its robust pipeline with 12 new actives, including 5 biologicals, for launch in the next decade.

USA – Corteva has completed the separation of its seed business and begun a new chapter as a focused, innovation-led global crop protection company, positioning the business to accelerate research, commercialization and delivery of technologies aimed at protecting crop yields.
The company announced the completion of the spin-off on October 1, 2026, creating a pure-play crop protection business with a renewed focus on innovation, operational efficiency and customer needs.
The separation follows Corteva’s 2025 decision to divide its Seed and Crop Protection businesses into Corteva and Vylor as independent public companies.
On September 21, 2026, Vylor and Belgian agtech company Rainbow Crops announced a collaboration to accelerate the development of novel gene-edited corn traits.
The company said the move reflects the increasingly different market opportunities and strategic requirements facing the two businesses, allowing each organization to concentrate investment and resources on its respective growth priorities.
Corteva begins its new phase with a pipeline containing 12 new active ingredients expected to reach the market over the next decade, including five biological products.
The company said this pipeline, combined with its established crop protection portfolio, provides a platform for future growth as farmers face increasing pressure from emerging pests and diseases, weed resistance and the need to improve productivity while using resources more efficiently.
The company is placing particular emphasis on technologies derived from or inspired by nature. Its innovation strategy covers four major areas: disease control, insect control, plant performance and weed control.
Corteva estimates these areas represent substantial global market opportunities and plans to combine conventional chemistry with nature-derived and nature-inspired solutions to provide farmers with more targeted crop protection options.
Biologicals are expected to become an increasingly important component of the portfolio.
Corteva begins this next chapter with strong momentum and a proven record of execution excellence. Between 2020 and 2025, the crop protection business increased revenue by over US$1 billion while expanding operating EBITDA margins by approximately 250 basis points on a segment basis.
This progress includes establishing an industry-leading biologicals and natural products platform and intentionally evolving the company’s product mix toward differentiated technologies, now representing about 65% of sales, to bring new, critically needed innovations to farmers.
Corteva CEO Luke Kissam said the new structure would provide greater focus and agility while strengthening the company’s commitment to innovation and operational excellence.
The company aims to use this focused model to respond more rapidly to changing agricultural challenges and deliver safe, effective and sustainable crop protection solutions.
The launch comes as farmers globally contend with resistance, climate-related production pressures and changing pest and disease patterns.
By concentrating exclusively on crop protection, Corteva intends to strengthen its position in a market where innovation in chemistry, biologicals and integrated crop health solutions will increasingly determine the competitiveness of agricultural inputs.
Sign up to HERE receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.